BATON ROUGE, Louisiana (July 15, 2010) - Amedisys, Inc. (NASDAQ: "AMED"), one of America's leading home health and hospice nursing companies, today announced that it has posted an open letter to shareholders on its website relating to recent events surrounding the company.
The letter can be accessed by following the link http://www.amedisys.com/pdf/letter_to_shareholders.pdf.
“We believe in communicating with our shareholders in an open manner,” stated William F. Borne, Chief Executive Officer of Amedisys, Inc. “We hope that this letter containing our perspective as of today is helpful in providing our investors with more information about our Company. Home health care is a critical part of the solution to our nation’s growing health care issues and Amedisys will continue to lead the way.”
Amedisys, Inc. (the “Company”) is headquartered in Baton Rouge, Louisiana. Our common stock trades on the NASDAQ Global Select Market under the symbol “AMED”.
Our company website address is www.amedisys.com. We use our website as a channel of distribution for important company information. Important information, including press releases, analyst presentations and financial information regarding our Company is routinely posted on and accessible on the Investor Relations subpage of our website, which is accessible by clicking on the tab labeled “Investors” on our website home page. We also use our website to expedite public access to time-critical information regarding our Company in advance of or in lieu of distributing a press release or a filing with the Securities and Exchange Commission (“SEC”) disclosing the same information. Therefore, investors should look to the Investor Relations subpage of our website for important and time-critical information. Visitors to our website can also register to receive automatic e-mail and other notifications alerting them when new information is made available on the Investor Relations subpage of our website. In addition, we make available on the Investor Relations subpage of our website (under the link “SEC filings”) free of charge our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, ownership reports on Forms 3, 4 and 5 and any amendments to those reports as soon as practicable after we electronically file such reports with the SEC. Further, copies of our Certificate of Incorporation and Bylaws, our Code of Ethical Business Conduct and the charters for the Audit, Compensation and Nominating and Governance Committees of our Board are also available on the Investor Relations subpage of our website (under the link “Corporate Governance”).
| Contact: | For Investors:
Amedisys, Inc.
Director of Investor Relations
Kevin B. LeBlanc
225.298.6391
kleblanc@amedisys.com | For Media:
Amedisys, Inc.
Senior Vice President Marketing & Communications
Jacqueline Chen Valencia
225.295.9688
jacqueline.chen@amedisys.com |
